98 results on '"Singer, Eric A."'
Search Results
2. Sex-based differences in the transcriptomic metabolic profiling in young onset colorectal cancer (YOCRC).
3. Family History and Risk of Renal Cell Carcinoma: A National Multiregister Case-Control Study.
4. Management of Metastatic Renal Clear Cell Cancer: ASCO Guideline Rapid Recommendation Update.
5. Publication rates of podium presentations at the Society of Gynecologic Oncology (SGO) annual meetings.
6. Radioisotope-guided Lymphadenectomy for Pelvic Lymph Node Staging in Patients With Intermediate- and High-risk Prostate Cancer (The Prospective SENTINELLE Study).
7. Survey of Informed Consent Procedures in Urology: Disclosing Resident Participation to Patients
8. Two is company, is three a crowd? Triplet therapy, novel molecular targets, and updates on the management of advanced renal cell carcinoma
9. The Promise of Neoadjuvant and Adjuvant Therapies for Renal Cancer
10. Integrating Surgery in the Multidisciplinary Care of Advanced Renal Cell Carcinoma
11. Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline Q&A
12. Model risk scores may underestimate rate of biochemical recurrence in African American men with localized prostate cancer: a cohort analysis of over 3000 men
13. Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline.
14. Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline.
15. Association of Lymph Node Count and Survival after Primary Retroperitoneal Lymphadenectomy for Nonseminomatous Testicular Cancer.
16. PD23-08 RETHINKING THE DEFINITION OF STAGE III IN ADRENOCORTICAL CARCINOMA: ASSESSING THE IMPACT OF CLINICAL LYMPH NODE POSITIVE DISEASE.
17. Non-infectious complications following transrectal prostate needle biopsy – Outcomes from over 8000 procedures
18. Quantifying Publication Rates and Time to Publication for American Urological Association Podium Presentations.
19. The roaring 2020s: a new decade of systemic therapy for renal cell carcinoma
20. The Legacy of Dr. Ron Rabinowitz: Studying the Past - Imagining the Future.
21. Impact of COVID-19 on Initial Management and Evaluation of Prostate Cancer
22. Assessment of Prostate Cancer Treatment Among Black and White Patients During the COVID-19 Pandemic
23. Fourteen-Core Systematic Biopsy That Includes Two Anterior Cores in Men With PI-RADS Lesion ≥ 3 is Comparable With Magnetic Resonance Imaging-ultrasound Fusion Biopsy in Detecting Clinically Significant Prostate Cancer: A Single-institution Experience
24. Observation with or without late radiotherapy is equivalent to early radiotherapy in high-risk prostate cancer after radical prostatectomy: A SEER-Medicare analysis on trends, survival outcomes, and complications
25. Impact of inflammatory bowel disease on radical prostatectomy outcomes and costs of care
26. A challenging frontier – the genomics and therapeutics of nonclear cell renal cell carcinoma
27. Phase Ib/II Clinical Trial of Pembrolizumab With Bevacizumab for Metastatic Renal Cell Carcinoma: BTCRC-GU14-003.
28. Six-Year-Old With Dysphagia
29. Factors Associated With Receipt of Partial Nephrectomy or Minimally Invasive Surgery for Patients With Clinical T1a and T1b Renal Masses: Implications for Regionalization of Care
30. Clinical targeting of HIV capsid protein with a long-acting small molecule
31. Phase I neoadjuvant study of intravesical recombinant fowlpox-GM-CSF (rF-GM-CSF) or fowlpox-TRICOM (rF-TRICOM) in patients with bladder carcinoma
32. Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014
33. Perioperative Advance Directives: Do Not Resuscitate in the Operating Room
34. Effect of alvimopan on gastrointestinal recovery and length of hospital stay after retroperitoneal lymph node dissection for testicular cancer.
35. P‐7.6: Powerful 30 seconds cycle time silicone optical bonding process for automotive applications
36. Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer
37. A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model
38. Implications of the Revised Common Rule for Human Participant Research
39. A Festschrift in Honor of Edward M. Messing, MD, FACS
40. Disparities in the Use of Continent Urinary Diversions after Radical Cystectomy for Bladder Cancer
41. Lessons Learned from the COVID-19 Pandemic: A Call for a National Video-Based Curriculum for Urology Residents
42. Second-Line Hormonal Therapy for Men With Chemotherapy-Naïve, Castration-Resistant Prostate Cancer: American Society of Clinical Oncology Provisional Clinical Opinion.
43. Pembrolizumab (pembro) monotherapy for patients (pts) with high-risk non–muscle-invasive bladder cancer (HR NMIBC) unresponsive to bacillus Calmette–Guérin (BCG): Results from cohort B of the phase 2 KEYNOTE-057 trial.
44. Final results of phase Ib/II study of durvalumab and guadecitabine in advanced clear cell renal cell carcinoma (ccRCC) and biomarker analysis.
45. Assessment of surgical complications in patients with metastatic clear cell renal cell carcinoma (mccRCC) receiving perioperative cabozantinib and nivolumab on Cyto-KIK clinical trial.
46. Impact of systemic therapy (ST) on deferred cytoreductive nephrectomy (CN) perioperative outcomes: A National Surgical Quality Improvement Program (NSQIP) analysis.
47. Polo-like kinase-1 as a potential prognostic marker of prostate cancer utilizing ORIEN data.
48. Androgen deprivation therapy for the treatment of prostate cancer: a focus on pharmacokinetics
49. Utilization of Pelvic Lymph Node Dissection for Patients With Low-Risk Prostate Cancer Treated With Robot-Assisted Radical Prostatectomy
50. Editorial Commentary
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.